跳转至内容
Merck
CN
  • Impaired extracellular matrix structure resulting from malnutrition in ovariectomized mature rats.

Impaired extracellular matrix structure resulting from malnutrition in ovariectomized mature rats.

Histochemistry and cell biology (2015-07-27)
Thaqif El Khassawna, Wolfgang Böcker, Katharina Brodsky, David Weisweiler, Parameswari Govindarajan, Marian Kampschulte, Ulrich Thormann, Anja Henss, Marcus Rohnke, Natali Bauer, Robert Müller, Andreas Deutsch, Anita Ignatius, Lutz Dürselen, Alexander Langheinrich, Katrin S Lips, Reinhard Schnettler, Christian Heiss
摘要

Bone loss is a symptom related to disease and age, which reflects on bone cells and ECM. Discrepant regulation affects cell proliferation and ECM localization. Rat model of osteoporosis (OVX) was investigated against control rats (Sham) at young and old ages. Biophysical, histological and molecular techniques were implemented to examine the underlying cellular and extracellular matrix changes and to assess the mechanisms contributing to bone loss in the context of aging and the widely used osteoporotic models in rats. Bone loss exhibited a compromised function of bone cells and infiltration of adipocytes into bone marrow. However, the expression of genes regulating collagen catabolic process and adipogenesis was chronologically shifted in diseased bone in comparison with aged bone. The data showed the involvement of Wnt signaling inhibition in adipogenesis and bone loss due to over-expression of SOST in both diseased and aged bone. Further, in the OVX animals, an integrin-mediated ERK activation indicated the role of MAPK in osteoblastogenesis and adipogenesis. The increased PTH levels due to calcium and estrogen deficiency activated osteoblastogenesis. Thusly, RANKL-mediated osteoclastogenesis was initiated. Interestingly, the data show the role of MEPE regulating osteoclast-mediated resorption at late stages in osteoporotic bone. The interplay between ECM and bone cells change tissue microstructure and properties. The involvement of Wnt and MAPK pathways in activating cell proliferation has intriguing similarities to oncogenesis and myeloma. The study indicates the importance of targeting both pathways simultaneously to remedy metabolic bone diseases and age-related bone loss.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
N,N-二甲基甲酰胺, ACS reagent, ≥99.8%
Sigma-Aldrich
甘油, ACS reagent, ≥99.5%
Sigma-Aldrich
甘油, Molecular Biology, ≥99.0%
Sigma-Aldrich
甘油, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
N,N-二甲基甲酰胺, anhydrous, 99.8%
Sigma-Aldrich
乙酸钠, anhydrous, ReagentPlus®, ≥99.0%
Sigma-Aldrich
乙酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
N,N-二甲基甲酰胺, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.8% (GC)
Sigma-Aldrich
甘油, ≥99.5%
Sigma-Aldrich
N,N-二甲基甲酰胺, ReagentPlus®, ≥99%
Sigma-Aldrich
乙酸钠, puriss. p.a., ACS reagent, reag. Ph. Eur., anhydrous
Sigma-Aldrich
甘油 溶液, 83.5-89.5% (T)
Sigma-Aldrich
N,N-二甲基甲酰胺, Molecular Biology, ≥99%
Sigma-Aldrich
甘油, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
甘油, BioUltra, Molecular Biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
乙酸钠, anhydrous, Molecular Biology, ≥99%
Sigma-Aldrich
甘油, BioXtra, ≥99% (GC)
Sigma-Aldrich
过氧化氢 溶液, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Sigma-Aldrich
苏木精
Sigma-Aldrich
N,N-二甲基甲酰胺, biotech. grade, ≥99.9%
Sigma-Aldrich
甘油, puriss., anhydrous, 99.0-101.0% (alkalimetric)
Sigma-Aldrich
乙酸钠, 99.995% trace metals basis
Sigma-Aldrich
甘油, FCC, FG
Sigma-Aldrich
过氧化氢 溶液, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
甘油, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Sigma-Aldrich
乙酸钠, >99%, FG
Sigma-Aldrich
甘油, meets USP testing specifications
Sigma-Aldrich
苏木精, certified by the BSC
Sigma-Aldrich
硫酸铝, 99.99% trace metals basis
Sigma-Aldrich
乙酸钠, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.0%